ClubWeightLoss.com

Related Articles

Increased Prevalence of Glycoprotein IIb/IIIa Leu33Pro Polymorphism in Term Infants with Grade I Intracranial Haemorrhage.

Neuropediatrics. 2006 Apr;37(2):67-71

Authors: Havasi V, Komlósi K, Bene J, Melegh B

The prevalence rates of the platelet glycoprotein IIb/IIIa Leu33Pro allele (PLA2), and factor V G1691A Leiden mutation were determined in 109 appropriate for gestational age neonates with grade I intraventricular haemorrhage (IVH) and in 118 IVH-free control infants. The PLA2 allele frequency was 16.4 % in the group of full-term infants with grade I IVH, while it was 9.5 % in the relevant controls (p < 0.005); there was no difference in the PLA allele frequencies on comparing the IVH affected (8.34 %) and unaffected (9.2 %) premature infants. By contrast, the factor V Leiden allele frequency was increased only in the subgroup of premature infants with grade I IVH as compared with the appropriate premature controls (9.25 % vs. 3.34 %, respectively, p < 0.005). These data suggest that besides the factor V Leiden mutation, the PLA2 allele, which has already been suggested to have a role in neonatal alloimmune thrombocytopenia and certain subtypes of adult stroke, can have significance in the development of the events of IVH.

PMID: 16773503 [PubMed - in process]

Related posts:

1. Early neonatal hypotension in premature infants born to preeclamptic mothers.
2. Use of a Nonmedicated Dietary Supplement Correlates with Increased Prevalence of Streptomycin-Sulfa-Tetracycline-Resistant Escherichia coli on a Dairy Farm.
3. Neurologic Condition of Healthy Term Infants at 18 Months: Positive Association With Venous Umbilical DHA Status and Negative Association With Umbilical Trans-fatty Acids.
4. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice*
5. Effects of antenatal magnesium sulfate and corticosteroid therapy on sleep states of preterm infants.

This entry was posted on Sunday, June 18th, 2006 at 12:06 pm and is filed under Health Research. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.